# Oxygenation of the Cerebrum and Cooling During Transcatheter Aortic Valve Implantation (TAVI) Procedures - Part II

> **NCT01822964** · NA · UNKNOWN · sponsor: **Hasselt University** · enrollment: 30 (estimated)

## Conditions studied

- Aortic Valve Stenosis
- Stroke

## Interventions

- **DEVICE:** targeted brain cooling (33°C) by RhinoChill device
- **DEVICE:** Placebo - current clinical practice, no cooling

## Key facts

- **NCT ID:** NCT01822964
- **Lead sponsor:** Hasselt University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01822964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01822964, "Oxygenation of the Cerebrum and Cooling During Transcatheter Aortic Valve Implantation (TAVI) Procedures - Part II". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01822964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*